Glucocorticoid receptor modulators

Ann Endocrinol (Paris). 2018 Jun;79(3):107-111. doi: 10.1016/j.ando.2018.03.004. Epub 2018 May 3.

Abstract

The glucocorticoid hormone cortisol acts throughout the body to support circadian processes and adaptation to stress. The glucocorticoid receptor is the target of cortisol and of synthetic glucocorticoids, which are used widely in the clinic. Both agonism and antagonism of the glucocorticoid receptor may be beneficial in disease, but given the wide expression of the receptor and involvement in various processes, beneficial effects are often accompanied by unwanted side effects. Selective glucocorticoid receptor modulators are ligands that induce a receptor conformation that allows activation of only a subset of downstream signaling pathways. Such molecules thereby combine agonistic and antagonistic properties. Here we discuss the mechanisms underlying selective receptor modulation and their promise in treating diseases in several organ systems where cortisol signaling plays a role.

Keywords: Brain; Cancer; Cerveau; Co-activateurs; Coactivators; Cortisol; Disease; Effets secondaires; Glucocorticoids; Glucocorticoïdes; Maladie; Metabolism; Métabolisme; Side effects; Stress.

Publication types

  • Review

MeSH terms

  • Animals
  • Aza Compounds / pharmacology
  • Glucocorticoids / agonists
  • Glucocorticoids / antagonists & inhibitors
  • Glucocorticoids / pharmacology*
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Humans
  • Ligands*
  • Mifepristone / pharmacology
  • Receptors, Glucocorticoid / agonists
  • Receptors, Glucocorticoid / antagonists & inhibitors*
  • Receptors, Glucocorticoid / metabolism*
  • Signal Transduction / drug effects
  • Thymine / analogs & derivatives
  • Thymine / pharmacology

Substances

  • Aza Compounds
  • CORT 108297
  • CORT118335
  • Glucocorticoids
  • Heterocyclic Compounds, 4 or More Rings
  • Ligands
  • Receptors, Glucocorticoid
  • Mifepristone
  • Thymine